Benitec Biopharma Inc. Gains 81.36%
Mon, Jun 26, 2023 at 07:38 PM
Benitec Biopharma Inc. (BNTC:NASDAQ) soared at $0.36, representing a gain of 81.4%. On Mon, Jun 26, 2023, BNTC:NASDAQ touched a New 2-Week High of $0.36. The stock appeared on our News Catalysts scanner on Mon, Jun 26, 2023 at 12:02 PM in the 'BIOTECH' category. From Mon, Jun 12, 2023, the stock recorded 11.11% Up Days and 20.00% Green Days
The stock spiked on Mon, Jun 26, 2023 at $0.53 with a volume of 182M+.
About Benitec Biopharma Inc. (BNTC:NASDAQ)
Benitec Biopharma Ltd is a biotechnology company which develops therapeutic technology platform that combines gene silencing and gene therapy which cures disease causing genes from single administration.
Top 10 Gainers:
- Trxade Group, Inc. (MEDS:NASDAQ), 93.84%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 81.36%
- MoonLake Immunotherapeutics Com (MLTX:NASDAQ), 77.55%
- Spark Networks SE (LOV:NASDAQ), 50.04%
- iMedia Brands, Inc. (IMBI:NASDAQ), 35.71%
- ACELYRIN INC. (SLRN:NASDAQ), 35.41%
- Shengfeng Development Limited (SFWL:NASDAQ), 33.2%
- Adagene Inc. (ADAG:NASDAQ), 30.37%
- Chemomab Therapeutics Ltd. (CMMB:NASDAQ), 28%
- Pharvaris N.V. (PHVS:NASDAQ), 27.76%